Skip to content

Author

M. Karsy

We have 7 of 374 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Nov 2026

Neurovascular conflict patterns in glossopharyngeal neuralgia: a systematic review and meta-analysis of offending vessels and outcomes after microvascular decompression

Background: Microvascular decompression (MVD) for glossopharyngeal neuralgia (GPN) presumes a compressive neurovascular conflict at the glossopharyngeal-vagal root entry zone, but the distribution of offending vessels has never been quantified across series. Objective: To estimate the pooled prevalence of each offendin...

K. Gupta, Maryam Zeinali, Joshua A. Benton et al. · 0 citations
Review Open access Oct 2026

Perioperative immune checkpoint inhibition in head and neck squamous cell carcinoma: a 10-year review

Immune checkpoint blockade has transformed management of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC), yet efforts to integrate immunotherapy into curative chemoradiation have failed to improve outcomes. We conducted a narrative review of English-language literature published between 2015 and 2...

Henry Freeman, C. Rawson, Nadir Al-Saidi et al. · 0 citations
Oct 2026

Predicting Failure to Rescue After Surgery for Degenerative Cervical Myelopathy: An ACS-NSQIP Analysis (2015-2020).

BACKGROUND CONTEXT Failure to rescue (FTR), defined as 30-day mortality among patients who experienced a major complication, has emerged as a quality metric in spine surgery. Recent FTR analyses report high discrimination using prediction models combining pre- and postoperative variables into a single model. Whether th...

Seán T. Kelleher, Jerick Kim, Shubhang Bhalla et al. · 0 citations
Oct 2026

Safety and Efficacy of Repeat Surgery for Recurrent Craniopharyngiomas: A RAPID Consortium Collaboration.

BACKGROUND AND OBJECTIVES Craniopharyngiomas (CPs) recur in 20% to 50% of cases after initial management. To date, there are no large multi-institutional series investigating outcomes in patients receiving surgery for recurrent CP. Here, we leverage the Registry of Adenomas of the Pituitary and Related Disorders to ana...

R. Shih, Maya Harary, M. Bergsneider et al. · 0 citations
Review Open access Aug 2026

Diagnostic evaluation of suspected aneurysmal subarachnoid hemorrhage after negative CT: risk-stratified use of lumbar puncture and CT angiography

Aneurysmal subarachnoid hemorrhage (SAH) is a neurologic emergency in which delayed or missed diagnosis can result in substantial morbidity and mortality. In patients who present with clinical features concerning for SAH but have a normal or non-diagnostic non-contrast head computed tomography (CT), the optimal next di...

C. Rawson, Yashieta Somani, M. Karsy et al. · 0 citations
Review Open access Oct 2026

The Tumor Neuroimmune Niche: A Unifying Framework for Cancer Progression and Its Neuropsychiatric Burden.

BACKGROUND Cancer has traditionally been framed as a cell-intrinsic genetic disease and, more recently, as a disorder of the tumor microenvironment (TME). An emerging third view reframes malignancy as a systems-level neuroimmune disorder, in which neurons, glia, immune cells, and tumor cells form a continuously communi...

Agastya Mittal, C. Rawson, Jaime Tellez et al. · 0 citations
Review Open access Aug 2026

Optimization of Focused Ultrasound-Mediated Blood–Brain Barrier Opening for CNS Therapeutic Delivery: Mechanistic Insights, Technical Parameters, and Clinical Translation

BBB microdisruption, particularly through FUS with microbubbles, represents a transformative platform for central nervous system gene therapy, and continued research is needed to standardize treatment protocols, characterize long-term safety, and facilitate broader clinical translation.

M. Rashad, Agastya Mittal, Srivardhan Chirasani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.